aminoglutethimide has been researched along with androstenedione in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 62 (51.24) | 18.7374 |
1990's | 47 (38.84) | 18.2507 |
2000's | 11 (9.09) | 29.6817 |
2010's | 1 (0.83) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cole, PA; Robinson, CH | 1 |
Bartz, U; Bayer, H; Grün, G; Hartmann, RW; Mitrenga, M; Sergejew, T | 1 |
Bayer, H; Grün, G; Hartmann, RW | 1 |
Barmade, MA; Murumkar, PR; Tamboli, RS; Yadav, MR | 1 |
Harvey, H; Lipton, A; Samojlik, E; Santen, RJ; Veldhuis, J; Wells, SA | 1 |
Audi, L; Collu, R; Ducharme, JR; Jéquier, JC; Laurin, P; Morera, AM; Saez, J | 1 |
Samojlik, E; Santen, RJ | 2 |
Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA | 1 |
Davis, B; Ruby, E; Samojlik, E; Santen, RJ; Santner, S; Veldhuis, J | 1 |
Beyer, C; Larsson, K; Morali, G | 1 |
Brown, PW; Lawrence, W; Newsome, HH; Terz, JJ | 1 |
deAsis, DN; Samaan, NA | 1 |
Dilley, WG; Haagensen, DE; Harvey, H; Lipton, A; Ruby, EJ; Santen, RJ; Wells, SA | 1 |
Samojlik, E; Santen, RJ; Wells, SA | 1 |
Ahrén, K; Bauminger, S; Collins, WP; Lieberman, ME; Lindner, HR; Tsafriri, A | 1 |
Beyer, C; Larsson, K; Moralí, G; Naftolin, F | 1 |
Ahrén, K; Dekel, N; Hillensjö, T | 1 |
Ahmadi, M; Nazareth, W; Nicholls, PJ; Smith, HJ; Whomsley, R | 1 |
Bogart, MH; Lance, VA | 1 |
Borja, J; Pérez, N | 1 |
Hisamatsu, K; Nomura, Y; Tashiro, H | 1 |
Dowsett, M; Ekse, D; Jacobs, S; Johannessen, DC; Jones, A; Lønning, PE; McNeil, F; Powles, TJ | 1 |
Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A | 1 |
Dowsett, M; Griggs, L; Haynes, B; Jacobs, S; Lønning, PE | 1 |
Bellora, MG; Bergamino, T; Ciancio, A; Ferrero, A; Sismondi, P; Zola, P | 1 |
Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
Chen, SA; Pompon, D; Zhou, DJ | 2 |
Dowsett, M; Lønning, PE; Powles, TJ | 1 |
Distler, W; von Matthiessen, H | 1 |
Santen, RJ | 1 |
Dowsett, M | 2 |
Briatico, G; di Salle, E; Giudici, D; Ornati, G | 1 |
Jarman, M; Laughton, CA; McCague, R; McKenna, R; Neidle, S; Rowlands, MG | 1 |
Dauvois, S; Labrie, F | 1 |
Bhatnagar, AS; Häusler, A; Krähenbühl, C; Monnet, G; Schenkel, L | 1 |
Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
Miller, WR | 1 |
Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E | 1 |
Manni, A; Santen, RJ | 1 |
Armstrong, DT; Glasier, MA; Khalil, MW; Lang, T; Morley, P | 1 |
Cantwell, BM; Dowsett, M; Harris, AL; Hill, M; Jeffcoate, SL; Smith, IE; Stuart-Harris, R | 1 |
Cantwell, BM; Dowsett, M; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R | 1 |
Alexieva-Figusch, J; de Jong, FH; Klign, JG; Lamberts, WJ; van Gilse, HA | 1 |
D'Souza, A; Donaldson, A; Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE; Stuart-Harris, R | 1 |
Payne, AH; Rani, CS | 1 |
Brodie, AM; Santen, RJ | 1 |
Dowsett, M; Jeffcoate, SL; Malone, P; Ponder, BA; Shearer, RJ | 1 |
Ayub, M; Levell, MJ | 1 |
Okada, H; Urabe, M; Yamamoto, T | 1 |
Miller, WR; O'Neill, J | 1 |
Griswold, T; Johnson, DC | 1 |
Feil, PD; Leszczynski, D; Manni, A; Santen, RJ; Santner, SJ; Tilson-Mallet, N; Wright, C | 1 |
Daly, MJ; Dyas, J; Nicholls, PJ; Pourgholami, MH; Smith, HJ | 1 |
Ahmann, FR; Crawford, ED; Kreis, W; Levasseur, Y | 1 |
Brodie, AM; Coombes, RC; Dowsett, M; Goss, P; Wing, LY | 1 |
Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC | 1 |
Donahoe, PK; Hutson, JM; MacLaughlin, DT | 1 |
Brodie, AM; Garrett, WM; Wing, LY | 1 |
Dowsett, M; Jeffcoate, SL; Santen, RJ; Santner, SJ; Smith, IE | 1 |
Siiteri, PK; Thompson, EA | 1 |
Gower, DB | 1 |
Carballeira, A; Durnhofer, F; Fishman, LM | 1 |
Jeffries, CD; Wilkins, J | 1 |
Gower, DB; Lessof, MH; Lyne, C | 1 |
Abul-Hajj, YJ | 2 |
Dowsett, M; Harris, AL; Jeffcoate, SL; McKinna, JA; Morgan, M; Smith, IE | 1 |
Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE | 2 |
Dowsett, M; Harris, AL; Jeffcoate, S; Smith, IE | 1 |
Chilvers, CE; Dowsett, M; Easton, D; Jeffcoate, SL; Miller, J; Pocock, RD; Ponder, BA; Shearer, RJ | 1 |
Smith, IE; Stuart-Harris, RC | 1 |
Powles, TJ | 1 |
Feil, PD; Santen, RJ; Santner, SJ; Tilson-Mallett, N | 1 |
Osawa, Y; Rosen, H; Santen, RJ; Santner, SJ | 1 |
Badder, EM; Lerman, S; Santen, R | 1 |
Brodie, AM | 2 |
Covey, DF; Etre, LA; MacIndoe, JH; Woods, GR | 1 |
Rabe, D; Rabe, T; Runnebaum, B | 1 |
Falvo, RE; Irwin, G; Samojlik, E; Santen, RJ; Worgul, TJ | 1 |
Check, WA | 1 |
Murray, R; Pitt, P | 1 |
Auzéby, A; Bogdan, A; Touitou, Y | 1 |
Aboul-Enein, HY; Ogbunude, PO | 1 |
Casebolt, TL; Eto, I; Grubbs, CJ; Kelloff, GJ; Lubet, RA; Steele, VE | 1 |
Cam, LL; Chen, S; Korzekwa, KR; Laughton, CA; Zhou, D | 1 |
Bhatnagar, AS; King, EJ; Purba, HS; Richert, P | 1 |
Dowsett, M; Jacobs, S; Lønning, PE; MacNeill, FA; Powles, TJ | 1 |
Kanno, H; Kim, T; Kitawaki, J; Noguchi, T; Okada, H; Yamamoto, T | 1 |
Höffken, K | 1 |
Ekse, D; Lønning, PE | 1 |
Düerkop, J; Hartmann, RW; Njar, VC | 1 |
Boyle, T; Dukes, M; Edwards, PN; Large, M; Smith, IK | 1 |
Frost, VJ; Helle, SI; Holly, JM; Lønning, PE; van der Stappen, JW | 1 |
Anker, G; Geisler, J; Johannessen, DC; Lønning, PE | 1 |
Durgam, VR; Tekmal, RR | 1 |
Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
Rubens, RD | 1 |
Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P | 1 |
Campbell, DR; Kurzer, MS | 1 |
Anker, GB; Johannessen, DC; Lien, EA; Lonning, PE; Refsum, H; Ueland, PM | 1 |
Ahmadi, M; Delgado, PO; Nicholls, PJ; Perez, SF; Simons, C; Smith, HJ; Vinh, TK; Walters, HM | 1 |
Blijham, GH; de Jong, PC | 1 |
Bonneterre, J; Feutrie, ML | 1 |
Harvey, HA; Santen, RJ | 1 |
Ohmori, K; Ohta, A; Sugawara, S; Yamada, K | 1 |
Bonneterre, J; Mauriac, L | 1 |
Auvray, P; Bichat, F; Genne, P | 1 |
de Crémoux, P | 1 |
Blanco, JG; Bocco, JL; Flury, A; Genti-Raimondi, S; Gil, RR; Meragelman, TL | 1 |
Cernich, J; Jacobson, JD; Moore, WV; Popovic, J | 1 |
King, HR; Lee, PS; Pankhurst, NW | 1 |
Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP | 1 |
Fox, J; Hamad, A; Kluk, M; Park, M; Turner, JE | 1 |
Dutta, U; Pant, K | 1 |
Menon, KM; Palaniappan, M | 1 |
Bond, CS; Dick, IM; Ingley, E; Payne, EJ; Prince, RL; Wilson, SG | 1 |
24 review(s) available for aminoglutethimide and androstenedione
Article | Year |
---|---|
Mechanism and inhibition of cytochrome P-450 aromatase.
Topics: Affinity Labels; Aromatase; Aromatase Inhibitors; Binding, Competitive; Humans; Molecular Structure; Photochemistry | 1990 |
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Female; Humans; Models, Molecular; Molecular Structure | 2015 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dexamethasone; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thyrotropin; Thyroxine | 1977 |
Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Letrozole; Nitriles; Triazoles | 1992 |
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Fadrozole; Female; Humans; Imidazoles; Menopause; Nitriles | 1990 |
Recent progress in development of aromatase inhibitors.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Humans; Imidazoles; Nitriles | 1990 |
Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Estrogen Antagonists; Fadrozole; Humans; Imidazoles; Nitriles | 1990 |
Aromatase inhibitors in the treatment of advanced breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Neoplasms, Hormone-Dependent; Nitriles | 1989 |
Clinical use of aromatase inhibitors in the treatment of breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Estrogens; Female; Humans | 1988 |
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen | 1986 |
Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aminoglutethimide; Androstenedione; Animals; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Sulfatases; Testolactone | 1986 |
Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aminoglutethimide; Androgens; Androstenedione; Animals; Cholesterol; Dexamethasone; Estrogens; Estrone; Glutethimide; Hormones; Humans; Hydrocortisone; Methane; Metyrapone; Microscopy, Electron; Pharmacology; Phenols; Pregnenolone; Pyridines; Steroid Hydroxylases; Steroids; Time Factors | 1974 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Aromatase, its inhibitors and their use in breast cancer treatment.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Half-Life; Humans; Neoplasms, Hormone-Dependent; Pargyline | 1993 |
Experience with aromatase inhibitors in the treatment of advanced breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Forecasting; Humans | 1993 |
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles | 1999 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
[Preclinical evaluation of aromatase inhibitors antitumor activity].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Models, Animal; Nitriles; Rats; Structure-Activity Relationship; Triazoles | 2000 |
[Aromatase inhibitors: pharmacological aspects].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
Use of aromatase inhibitors in children with short stature.
Topics: Adult; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Body Height; Child; Estrogens; Female; Growth Disorders; Humans; Letrozole; Male; Musculoskeletal System; Nitriles; Triazoles | 2004 |
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2006 |
Aromatase inhibitors: past, present and future in breast cancer therapy.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2008 |
10 trial(s) available for aminoglutethimide and androstenedione
Article | Year |
---|---|
Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Middle Aged; Pilot Projects | 1992 |
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Receptors, Estrogen | 1989 |
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen | 1986 |
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Time Factors | 1984 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
The role of aromatase inhibitors in breast cancer.
Topics: Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrone; Female; Humans; Menopause; Middle Aged; Oxidoreductases; Prognosis | 1983 |
Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Staging; Ovariectomy; Postmenopause | 1995 |
Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Middle Aged | 1996 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine | 1997 |
89 other study(ies) available for aminoglutethimide and androstenedione
Article | Year |
---|---|
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.
Topics: Adrenal Glands; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cattle; Female; Humans; Liver; Male; Mammary Neoplasms, Experimental; Naphthalenes; Ovary; Placenta; Pyridines; Rats; Testis | 1995 |
Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Cattle; Female; Humans; Indans; Mammary Neoplasms, Experimental; Microsomes; Molecular Structure; Organ Size; Placenta; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Testosterone; Tetrahydronaphthalenes; Uterus | 1994 |
Mechanism of action of aminoglutethimide in breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrone; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Testosterone | 1979 |
Further studies on the relationship of adrenal and gonadal steroids in pubertal development in female rats.
Topics: Adrenal Glands; Adrenalectomy; Age Factors; Aminoglutethimide; Androstenedione; Animals; Corticosterone; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Rats; Sexual Maturation | 1979 |
Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
Topics: 17-alpha-Hydroxypregnenolone; Aminoglutethimide; Androgens; Androstenedione; Breast Neoplasms; Castration; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hydroxyprogesterones; Menopause; Progesterone; Progestins | 1978 |
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
Topics: Adult; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged | 1978 |
Inhibition of testosterone-induced sexual behavior in the castrated male rat by aromatase blockers.
Topics: Aminoglutethimide; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Castration; Copulation; Dihydrotestosterone; Estradiol; Male; Oxidoreductases; Rats; Sexual Behavior, Animal; Testosterone | 1977 |
Medical adrenalectomy and plasma steroids in advanced breast carcinoma.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Aminoglutethimide; Androstenedione; Breast Neoplasms; Depression, Chemical; Dexamethasone; Estradiol; Estrone; Female; Humans; Hydrocortisone | 1978 |
Feminizing adrenocortical carcinoma with Cushing's syndrome and pseudohyperparathyroidism.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Aminoglutethimide; Androstenedione; Cushing Syndrome; Dexamethasone; Estrogens; Feminization; Humans; Hyperparathyroidism; Male; Metyrapone; Mitotane; Paraneoplastic Endocrine Syndromes; Parathyroid Hormone; Testosterone | 1978 |
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Estrogens; Female; Follow-Up Studies; Humans; Hypophysectomy; Lung Neoplasms; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Radiography; Remission, Spontaneous; Thyrotropin; Thyroxine; Time Factors | 1978 |
Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Breast Neoplasms; Castration; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Male; Menopause | 1977 |
Oocytic meiosis in cultured rat follicles during inhibition of steroidogenesis.
Topics: Aminoglutethimide; Androstenedione; Animals; Culture Media; Culture Techniques; Cyanoketone; Depression, Chemical; Estradiol; Female; Luteinizing Hormone; Meiosis; Oocytes; Ovarian Follicle; Ovum; Progesterone; Prostaglandins E; Radioimmunoassay; Rats; Secretory Rate | 1976 |
Effect of some antiestrogens and aromatase inhibitors on androgen induced sexual behavior in castrated male rats.
Topics: Aminoglutethimide; Androstenedione; Animals; Castration; Clomiphene; Drug Interactions; Ejaculation; Ethamoxytriphetol; Male; Metyrapone; Rats; Sexual Behavior, Animal; Tamoxifen; Testosterone; Time Factors | 1976 |
Effects of gonadotrophins on the cumulus oophorus of isolated rat Graafian follicles.
Topics: Aminoglutethimide; Androstenedione; Animals; Cyanoketone; Drug Interactions; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Hyaluronoglucosaminidase; Luteinizing Hormone; Oocytes; Ovarian Follicle; Ovum; Progesterone; Prolactin; Rats | 1976 |
Some 1-, and 3-substituted 3-(4'-aminophenyl)pyrrolidine-2,5-diones as selective inhibitors of aromatase.
Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Aniline Compounds; Animals; Aromatase Inhibitors; Cattle; Humans; Microsomes, Liver; Placenta; Rats; Structure-Activity Relationship; Succinimides; Testosterone | 1992 |
Disruption of ovarian development in alligator embryos treated with an aromatase inhibitor.
Topics: Alligators and Crocodiles; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Estradiol; Fadrozole; Female; Imidazoles; Male; Nitriles; Ovary; Tamoxifen; Testis | 1992 |
[Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Estrone; Female; Humans; Middle Aged; Survival Rate; Tamoxifen | 1992 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Thyroxine; Triiodothyronine | 1991 |
Measurement of aromatisation by a urine technique suitable for the evaluation of aromatase inhibitors in vivo.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Estrone; Female; Humans | 1991 |
[The use of aminoglutethimide in the treatment of metastatic breast cancer].
Topics: Adrenal Glands; Age Factors; Aminoglutethimide; Androstenedione; Breast Neoplasms; Female; Humans; Menopause; Neoplasm Metastasis | 1991 |
Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg.
Topics: Amino Acid Sequence; Aminoglutethimide; Androstenedione; Animals; Arginine; Aromatase; Base Sequence; Cell Line; Humans; Kinetics; Leucine; Molecular Sequence Data; Molecular Weight; Mutagenesis, Site-Directed; Oligonucleotide Probes; Phenylalanine; Proline; Substrate Specificity; Testosterone; Transfection; Tyrosine | 1991 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Base Sequence; Blotting, Southern; Cricetinae; Cricetulus; DNA; Female; Gene Expression; Humans; Kinetics; Molecular Sequence Data; Ovary; Placenta; Plasmids; Polymerase Chain Reaction; Pregnancy; Transfection; Tumor Cells, Cultured | 1990 |
Novel irreversible aromatase inhibitors.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Female; Gonadotropins, Equine; Humans; In Vitro Techniques; Kinetics; Microsomes; Ovary; Pargyline; Placenta; Rats; Rats, Inbred Strains | 1990 |
Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Chemical Phenomena; Chemistry; Crystallography; Humans; Models, Molecular; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship | 1990 |
Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Androstenediol; Androstenediols; Androstenedione; Animals; Aromatase; Female; Flutamide; Mammary Neoplasms, Experimental; Ovariectomy; Rats; Rats, Inbred Strains; Silicone Elastomers | 1989 |
An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Cricetinae; Estrogen Antagonists; Estrogens; Estrus; Fadrozole; Female; Imidazoles; Kinetics; Luteinizing Hormone; Mesocricetus; Nitriles; Ovary; Progesterone; Testolactone; Testosterone | 1989 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
Formation of 4-oestrene-3,17-dione (19-norandrostenedione) by porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole.
Topics: Aminoglutethimide; Androstenedione; Animals; Cells, Cultured; Female; Granulosa Cells; Ketoconazole; Swine | 1989 |
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression, Chemical; Drug Combinations; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Time Factors | 1985 |
Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause | 1986 |
Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Hormones; Humans; Hydrocortisone; Middle Aged; Sex Hormone-Binding Globulin; Thyrotropin; Thyroxine | 1987 |
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.
Topics: Adrenocorticotropic Hormone; Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Depression, Chemical; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Oxidoreductases; Testosterone | 1985 |
Adenosine 3',5'-monophosphate-mediated induction of 17 alpha-hydroxylase and C 17-20 lyase activities in cultured mouse Leydig cells is enhanced by inhibition of steroid biosynthesis.
Topics: Aldehyde-Lyases; Aminoglutethimide; Androstenedione; Animals; Cyclic AMP; Cytochrome P-450 Enzyme System; Enzyme Induction; Estradiol; Hydroxysteroid Dehydrogenases; Leydig Cells; Male; Mice; Microsomes; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Testosterone | 1986 |
The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Humans; Hydrocortisone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone; Time Factors | 1988 |
Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Humans; Imidazoles; Ketoconazole; Microsomes; Placenta; Structure-Activity Relationship | 1988 |
[The inhibitory effect of miconazole on aromatase activity for androstenedione in human placental and ovarian preparations].
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Female; Humans; In Vitro Techniques; Miconazole; Ovary; Placenta; Pregnancy; Testolactone | 1987 |
Mammary steroidogenesis: therapeutic implications.
Topics: 17-Hydroxysteroid Dehydrogenases; Adipose Tissue; Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; In Vitro Techniques | 1987 |
Relationship between in vivo and in vitro 17 alpha-hydroxylase and C17,20-lyase activity in ovaries of immature hypophysectomized rats treated chronically with human chorionic gonadotropin.
Topics: 17-alpha-Hydroxyprogesterone; Aldehyde-Lyases; Aminoglutethimide; Androstenedione; Animals; Chorionic Gonadotropin; Cycloheximide; Dactinomycin; Female; Hydroxyprogesterones; Hypophysectomy; In Vitro Techniques; Microsomes; Mitochondria; Ovary; Rats; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases | 1986 |
Inhibition of aromatase activity in the rat by aminoglutethimide and related compounds.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Female; Ovary; Rats; Rats, Inbred Strains; Testosterone | 1987 |
Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
Topics: Aminoglutethimide; Androgens; Androstenedione; Drug Therapy, Combination; Humans; Hydrocortisone; Male; Orchiectomy; Prostatic Neoplasms; Testosterone | 1987 |
Aromatase inhibitors and the treatment of breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Macaca mulatta; Mammary Neoplasms, Experimental; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Rats; Tamoxifen | 1986 |
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen | 1986 |
Steroid modulation of Mullerian duct regression in the chick embryo.
Topics: Aminoglutethimide; Androstenedione; Animals; Anti-Mullerian Hormone; Chick Embryo; Drug Interactions; Estrogen Antagonists; Estrogens; Female; Glycoproteins; Growth Inhibitors; Male; Mullerian Ducts; Norethindrone; Pyrrolidines; Tamoxifen; Testicular Hormones; Thiophenes | 1985 |
Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Estrus; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Oxidoreductases; Pregnancy; Rats; Rats, Inbred Strains | 1985 |
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
Topics: Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrone; Female; Humans; Middle Aged; Oxidoreductases | 1985 |
The involvement of human placental microsomal cytochrome P-450 in aromatization.
Topics: Aminoglutethimide; Androstenedione; Animals; Binding Sites; Binding, Competitive; Carbon Monoxide; Cyanides; Cytochrome P-450 Enzyme System; Cytochrome Reductases; Female; Humans; Kinetics; Metyrapone; Microsomes; Microsomes, Liver; Nandrolone; Placenta; Pregnancy; Proadifen; Protein Binding; Rabbits; Receptors, Cell Surface; Spectrophotometry; Spectrophotometry, Ultraviolet; Steroids; Swine; Tritium | 1974 |
Effects of aminoglutethimide, metyrapone, and ascorbic acid on testicular metabolism of cholesterol.
Topics: Aminoglutethimide; Androstanes; Androstenedione; Animals; Ascorbic Acid; Carbon Radioisotopes; Cell-Free System; Cholesterol; Chromatography, Paper; Chromatography, Thin Layer; Female; Hydroxyprogesterones; Hydroxysteroids; Male; Metyrapone; Mitochondria; Pregnenolone; Progesterone; Rats; Testis; Testosterone; Tritium | 1974 |
Effect of exogenous steroids and inhibitors of steroidogenesis on endotoxin shock.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aminoglutethimide; Androstenedione; Animals; Butanones; Corticosterone; Desoxycorticosterone; Endotoxins; Hydrocortisone; Hydroxyprogesterones; Lethal Dose 50; Male; Metyrapone; Mice; Mice, Inbred ICR; Pregnenes; Pregnenolone; Progesterone; Shock, Septic | 1973 |
Proceedings: Effects of aminoglutethimide and SU 10'603 on the biosynthesis of C19 steroids.
Topics: Aminoglutethimide; Androstenedione; Animals; Carbon Radioisotopes; Cholesterol; In Vitro Techniques; Male; Mixed Function Oxygenases; Naphthalenes; Pregnenolone; Progesterone; Pyridines; Rats; Steroids; Swine; Testis; Testosterone | 1974 |
Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
Topics: Aminoglutethimide; Androgens; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cyanoketone; Dehydroepiandrosterone; Estrogens; Female; Humans; Kinetics; Oxidoreductases; Receptors, Estrogen | 1982 |
Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
Topics: Adult; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Estradiol; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Menstruation; Middle Aged | 1982 |
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cosyntropin; Dehydroepiandrosterone; Drug Administration Schedule; Drug Therapy, Combination; Estrone; Female; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged | 1983 |
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Hormones; Humans; Hydrocortisone; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prolactin | 1984 |
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Cortisone; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Neoplasms; Sleep Stages; Testosterone | 1984 |
Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis.
Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Stereoisomerism | 1980 |
Biological significance of aromatase activity in human breast tumors.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrone; Female; Humans; Oxidoreductases; Receptors, Estrogen; Receptors, Progesterone; Testolactone | 1983 |
Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy; Substrate Specificity; Testolactone; Testosterone Congeners | 1984 |
Aminoglutethimide stimulates extra adrenal delta-4-androstenedione production.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aminoglutethimide; Androstenedione; Animals; Castration; Dogs; Female; Hydrocortisone; Hydroxyprogesterones | 1983 |
Overview of recent development of aromatase inhibitors.
Topics: Aminoglutethimide; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; In Vitro Techniques; Macaca mulatta; Male; Oxidoreductases; Pregnancy; Rats | 1982 |
Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line; Dihydrotestosterone; Estradiol; Female; Humans; Oxidoreductases; Pargyline; Receptors, Estrogen; Receptors, Progesterone; Testolactone; Testosterone | 1982 |
New aromatase assay and its application for inhibitory studies of aminoglutethimide on microsomes of human term placenta.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy | 1982 |
Evidence that brain aromatization regulates LH secretion in the male dog.
Topics: Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Brain; Dihydrotestosterone; Dogs; Estradiol; Estrogens; Estrone; Feedback; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Oxidoreductases; Testosterone | 1981 |
Medical adrenalectomy may replace surgery for advanced breast cancer.
Topics: Adipose Tissue; Adrenal Glands; Adrenalectomy; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cholesterol; Estradiol; Estrogen Antagonists; Female; Humans; Pregnenolone | 1980 |
Inhibition of androgen aromatization in human breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Estradiol; Estrone; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy | 1980 |
An alternate pathway to androstenedione synthesis by human adrenals: evidence of a balance in 11 beta-hydroxylase and 17,20-lyase activities leading to androstenedione.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Aged; Aldehyde-Lyases; Aminoglutethimide; Androstenedione; Carcinoma; Child; Cytochrome P-450 Enzyme System; Female; Humans; Hyperaldosteronism; Male; Metyrapone; Middle Aged; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase | 1995 |
In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Female; Glutethimide; In Vitro Techniques; Microsomes; Ovary; Rats; Stereoisomerism | 1994 |
Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
Topics: Adenocarcinoma; Aminoglutethimide; Androstenedione; Animals; Anticarcinogenic Agents; Aromatase Inhibitors; Drug Screening Assays, Antitumor; Estrus; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triazoles | 1994 |
Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.
Topics: Amino Acid Sequence; Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Computer Simulation; DNA Mutational Analysis; Dose-Response Relationship, Drug; Fadrozole; Models, Molecular; Molecular Sequence Data; Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship | 1994 |
Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Binding, Competitive; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol; Estrone; Fadrozole; Female; Ketoconazole; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Steroid Hydroxylases; Substrate Specificity | 1994 |
Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Estrogens; Female; Humans; Middle Aged; Postmenopause; Radioisotope Dilution Technique | 1994 |
Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening.
Topics: Aminoglutethimide; Androstenedione; Androstenols; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Fadrozole; Female; Humans; Kinetics; Tumor Cells, Cultured | 1993 |
A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrone; Female; Humans; Hydrolysis; Menopause; Radioimmunoassay; Sensitivity and Specificity | 1995 |
Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Cyclopropanes; Enzyme Inhibitors; Enzyme Stability; Estradiol; Humans; Kinetics; Magnetic Resonance Spectroscopy; Microsomes; Molecular Structure; NADP; Placenta; Steroids; Testosterone | 1996 |
The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor.
Topics: Adrenal Glands; Aminoglutethimide; Anastrozole; Androstenedione; Animals; Aromatase Inhibitors; Cortodoxone; Enzyme Inhibitors; Fadrozole; Female; Hormones; Humans; Macaca nemestrina; Male; Metyrapone; Nitriles; Organ Size; Potassium; Prostate; Rats; Rats, Wistar; Seminal Vesicles; Sodium; Triazoles; Uterus | 1996 |
Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Endopeptidases; Female; Humans; Insulin-Like Growth Factor Binding Proteins; Megestrol Acetate; Middle Aged; Radioimmunoassay; Somatomedins | 1996 |
Aromatase inhibitors come of age.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Nitriles; Triazoles | 1997 |
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured | 1997 |
Aromatase inhibitors for breast cancer--further progress.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol Acetate | 1997 |
Flavonoid inhibition of aromatase enzyme activity in human preadipocytes.
Topics: Adipocytes; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Humans; Kinetics; Molecular Structure | 1993 |
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Creatinine; Enzyme Inhibitors; Estrogen Antagonists; Homocysteine; Humans; Postmenopause; Vitamins | 1999 |
1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Benzofurans; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Ketones; Placenta; Pregnancy; Structure-Activity Relationship; Tetrazoles; Triazoles | 1999 |
Effect of 3,6-dimethylpyrazine-2-thiol on androstenedione-induced increase of uterine weight in female rats.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Organ Size; Pregnancy; Pyrazines; Rats; Rats, Wistar; Testosterone; Uterus | 1999 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Tamoxifen | 2000 |
Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Cell Line; Cell Survival; Choriocarcinoma; Dose-Response Relationship, Drug; Female; Humans; Hypertrophy; Lactones; Mice; Microsomes; Mitochondria; Organ Size; Placenta; Sesquiterpenes; Spectrum Analysis; Structure-Activity Relationship; Uterine Diseases; Uterine Neoplasms | 2001 |
Effects of aromatase inhibitors on in vitro steroidogenesis by Atlantic salmon (Salmo salar) gonadal and brain tissue.
Topics: Aminoglutethimide; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Brain; Estradiol; Fadrozole; Female; Miconazole; Ovarian Follicle; Salmo salar; Testosterone | 2006 |
The effects of aromatase inhibitors and selective estrogen receptor modulators on eye development in the zebrafish (Danio rerio).
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Clomiphene; Embryo, Nonmammalian; Embryonic Development; Estrogens; Eye; Retina; Selective Estrogen Receptor Modulators; Tamoxifen; Zebrafish | 2007 |
Regulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells.
Topics: Aminoglutethimide; AMP-Activated Protein Kinases; Analysis of Variance; Androgens; Androstenedione; Animals; Cells, Cultured; Cholesterol; Chorionic Gonadotropin; Female; Gene Expression Regulation; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Insulin; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Steroid 17-alpha-Hydroxylase; Sterol Regulatory Element Binding Protein 1; Theca Cells | 2009 |
In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Cell Line; Humans; Kinetics; Protein Structure, Secondary; Structure-Activity Relationship | 2009 |